Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06808334 · ClinicalTrials.gov registry record
CLAiR Pivotal Study
A clinical trial of No Condition, sponsored by Toku Eyes.
- Recruiting
- Registry status
- 942
- Enrollment target
- 1
- Study location
NCT06808334 is a study of No Condition that is actively recruiting participants, run by Toku Eyes. The registered enrollment target is 942 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06808334, a study of No Condition, is actively recruiting participants, sponsored by Toku Eyes.
- RECRUITING
- Registry status
- 942 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a multi-site, observational clinical study to validate the performance of the CLAiR AI software in identifying elevated atherosclerotic cardiovascular disease (ASCVD) risk from retinal (eye) images obtained from two different retinal image camera models.
Conditions Studied
Interventions
- OTHER CLAIR
Study Locations (1)
Ohio
- Diabetes and Endocrine Associates of Stark County - Canton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 942 participants |
| Start Date | 2025-02-27 |
| Est. Completion | 2025-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06808334
The ClinicalTrials.gov registry entry for NCT06808334 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 942 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Toku Eyes, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with No Condition appearing as the primary indexed condition, and to 1 intervention - of which CLAIR is the first listed.
NCT06808334 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06808334 about?
NCT06808334 is a clinical study titled "CLAiR Pivotal Study". This is a multi-site, observational clinical study to validate the performance of the CLAiR AI software in identifying elevated atherosclerotic cardiovascular disease (ASCVD) risk from retinal (eye) images obtained from two different retinal image camera models.
What is the current status of trial NCT06808334?
This trial is currently recruiting. The enrollment target is 942 participants. The study started on 2025-02-27. Estimated completion is 2025-10-01.
What conditions does trial NCT06808334 study?
This clinical trial studies the following conditions: No Condition.
What interventions are being tested in trial NCT06808334?
The interventions under investigation include: CLAIR (OTHER).
Who is sponsoring clinical trial NCT06808334?
This trial is sponsored by Toku Eyes, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06808334 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for No Condition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.